T. Wittwer et al., Retrograde flush perfusion with low-potassium solutions for improvement ofexperimental pulmonary preservation, J HEART LUN, 19(10), 2000, pp. 976-983
Background: Optimal preservation of post-ischemic organ function is a conti
nuing challenge in clinical lung transplantation. Retrograde instillation o
f preservation solutions has the theoretic advantage of achieving homogeneo
us distribution in the lung because of perfusing both the pulmonary and the
bronchial circulation. So far, we have seen no experimental studies that i
nclude stereologic analysis of intrapulmonary edema concerning the influenc
e of retrograde preservation on post-ischemic lung function after preservat
ion with Perfadex and Celsior,
Methods: In an extracorporeal rat model, we perfused 8 lungs, each, using e
ither antegrade or retrograde perfusion technique with Celsior (CEant/CEret
) and Perfadex (PERant/PERret). Results were compared with low-potassium Eu
ro-Collins. Postischemic lungs were reventilated and reperfused mechanicall
y. We continuously monitored relative oxygenation capacity (ROC), pulmonary
artery pressure, flush time, and wet/dry ratio. Furthermore, we used stere
ologic means to evaluate edema formation. Statistics comprised different an
alysis of variance models.
Results: Relative oxygen capacity of CEant-protected lungs was superior to
that of PERant preservation (p = 0.05). Use of PERret resulted in significa
ntly higher ROC as compared with PERant (p < 0.001) and was comparable to r
esults obtained with CE-preservation, which was not further improved with r
etrograde application.
Conclusion: Celsior provides better lung preservation than does Perfadex wh
en administered antegradely. Retrograde application of Perfadex results in
significant functional improvement as compared with antegrade perfusion, wh
ich reaches the standard of Celsior-protected organs. Additional in vivo ex
periments in combination with ultrastructural analysis are warranted to fur
ther evaluate retrograde delivery of preservation solutions, which could be
used in clinical lung transplantation to further optimize current results.